The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Systematic Review of Migraine Prophylaxis Adherence and Persistence
Open accessAbstract
BACKGROUND: Migraine is a common neurological disease affecting 12% of Americans and millions worldwide. Medication adherence has been studied extensively in many chronic conditions, with poor adherence adversely affecting treatment outcomes. However, little is known about adherence to oral prophylaxis for migraine. OBJECTIVE: To examine the literature on assessing oral prophylaxis medication adherence and persistence among migraine patients. METHODS: A systematic search of the PubMed (1966 to present) and EMBASE (1974 to present) databases was conducted to locate prospective and retrospective observational studies and randomized controlled trials (RCTs) of propranolol, amitriptyline, and topiramate. RCTs were pooled, weighted by sample size, and stratified by drug and length of study. Average persistence rates and reasons for discontinuation cited in RCTs were examined for each medication. RESULTS: A total of 788 unique articles were identified using the search criteria, 33 of which were included in the final review. Observational studies (n = 14) showed adherence ranges of 41% to 95% at 2 months, 21% to 80% at 6 months, and 35% to 56% at 12 months and persistence ranges of 41% to 88% at 2 months, 19% to 79% at 6 months, and 7% to 55% at 12 months. Pooled persistence from RCTs on propranolol, amitriptyline, and topiramate (n = 19) showed rates of 77%, 55%, and 57%, respectively, at 16-26 weeks. Adverse events were the most common reason for discontinuation cited (24% for topiramate and 17% for amitriptyline). CONCLUSION: Observational studies and pooled data from RCTs demonstrate poor adherence and persistence to oral migraine prophylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 1×
“8 Tension headache 27 (4-30); migraine 11 (1-30); tension + migraine 18 (2-30) 91% adherent at first fill, 39% at 5 months, and 35% at 12-18 months”
BackgroundDiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“8 Tension headache 27 (4-30); migraine 11 (1-30); tension + migraine 18 (2-30) 91% adherent at first fill, 39% at 5 months, and 35% at 12-18 months”
BackgroundPatient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F., & Nichol, M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 633
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S., & Smith, D. B. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.9.728 · Cited by 549
Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004) · Medical Care · doi:10.1097/01.mlr.0000129496.05898.02 · Cited by 519
Pill Count, Self-Report, and Pharmacy Claims Data to Measure Medication Adherence in the Elderly
Grymonpre, R. E., Didur, C. D., Montgomery, P. R., & Sitar, D. S. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17423 · Cited by 214
Hazard, E., Munakata, J., Bigal, M. E., Rupnow, M. F. T., & Lipton, R. B. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00404.x · Cited by 167
Gaul, C., van Doorn, C., Webering, N., Dlugaj, M., Katsarava, Z., Diener, H.-C., & Fritsche, G. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0348-y · Cited by 156
Dodick, D. W., Freitag, F. G., Banks, J., Saper, J. R., Xiang, J. X., Rupnow, M. F. T., Biondi, D. M., Greenberg, S. J., & Hulihan, J. F. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.03.020 · Cited by 151
Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial
Tfelt‐Hansen, P. C., Standnes, B., Kangasneimi, P., Hakkarainen, H., & Olesen, J. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07772.x · Cited by 146
Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
Couch, J. R., & for the Amitriptyline Versus Placebo Study Group (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01800.x · Cited by 143
Cady, R. K., Schreiber, C. P., Porter, J. A. H., Blumenfeld, A. M., & Farmer, K. U. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01796.x · Cited by 125
The Impact of Intensive Patient Education on Clinical Outcome in a Clinic‐Based Migraine Population
Rothrock, J. F., Parada, V. A., Sims, C., Key, K. F., Walters, N. S., & Zweifler, R. M. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00428.x · Cited by 124
A Comparison of Divalproex With Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Kaniecki, R. G. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210071015 · Cited by 118
Diener, H., Matías‐Guiu, J., Hartung, E., Pfaffenrath, V., Ludin, H. P., Nappi, G., de Beukelaar, F., & on behalf of the Study Group (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.t01-1-00309.x · Cited by 116
A Critical Evaluation of the Methodology of the Literature on Medication Compliance
Nichol, M. B., Venturini, F., & Sung, J. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18233 · Cited by 114
Zeller, A., Ramseier, E., Teagtmeyer, A., & Battegay, E. (2008) · Hypertension Research · doi:10.1291/hypres.31.2037 · Cited by 111
Noncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better
Mulleners, W., Whitmarsh, T., & Steiner, T. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1801052.x · Cited by 94
Keskinbora, K., & Aydınlı, I. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.05.025 · Cited by 78
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
Mei, D., Capuano, A., Vollono, C., Evangelista, M., Ferraro, D., Tonali, P., & Trapani, G. D. (2004) · Neurological Sciences · doi:10.1007/s10072-004-0350-0 · Cited by 72
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
Ashtari, F., Shaygannejad, V., & Akbari, M. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01087.x · Cited by 72
Thier, S. L., Yu-Isenberg, K. S., Leas, B. F., Cantrell, C. R., DeBussey, S., Goldfarb, N. I., & Nash, D. B. (2008) · PubMed · Cited by 69
Long-Acting Propranolol in Migraine Prophylaxis: Results of a Double-Blind, Placebo-Controlled Study
Pradalier, A., Serratrice, G., Collard, M., Hirsch, É., Fève, J. R., Masson, M., Masson, C., Dry, J., Koulikovsky, G., Nguyen, G.-T., et al. (1989) · Cephalalgia · doi:10.1046/j.1468-2982.1989.0904247.x · Cited by 65
Zonisamide Versus Topiramate in Migraine Prophylaxis
Mohammadianinejad, S. E., Abbasi, V., Sajedi, S. A., Majdinasab, N., Abdollahi, F., Hajmanouchehri, R., & Faraji, A. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318225140c · Cited by 60
Adelman, J. U., Freitag, F. G., Láinez, M. J. A., Shi, Y., Ascher, S., Mao, L., Greenberg, S. J., & Hulihan, J. F. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00389.x · Cited by 52
Domingues, R. B., da Silva, A. L. P., Domingues, S. C. A., Aquino, C., & Kuster, G. W. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000600002 · Cited by 41
Yaldo, A. Z., Wertz, D. A., Rupnow, M. F. T., & Quimbo, R. M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.010 · Cited by 39
Migraine Prophylactic Medication Usage Patterns in the Netherlands
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, T. C. G. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00494.x · Cited by 39
The Use of Migraine Preventive Medications Among Patients with and without Migraine Headaches
Lafata, J. E., Tunceli, O., Cerghet, M., Sharma, K., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01909.x · Cited by 39
Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo
Mikkelsen, B. O., Pedersen, K. K., & Christiansen, L. V. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb03299.x · Cited by 38
Rejection and Acceptance of Possible Side Effects of Migraine Prophylactic Drugs
Kowacs, P. A., Piovesan, É. J., & Tepper, S. J. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01431.x · Cited by 33
Preventive Medication Adherence in African American and Caucasian Headache Patients
Heckman, B. D., & Ellis, G. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01866.x · Cited by 17
Nelles, G., Schmitt, L., Humbert, T., Becker, V., Sandow, P., Bornhövd, K., Fritzsche, D., Schäuble, B., & on behalf of the TOPMATMIG-0001 investigators (2009) · The Journal of Headache and Pain · doi:10.1007/s10194-009-0163-x · Cited by 16
Topiramate vs. Amitriptyline in prophylactic treatment of migraine: A controlled clinical trial
Rodríguez‐Leyva, I., Sánchez-Aguilar, M., Hernández-Sierra, J. F., Mandeville, P. B., Leyva, M. D. R. R., Shiguetomi-Medina, J. M., & Tapia-Pérez, J. H. (2010) · Cited by 3
Cited by
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
Dodick, D. W., Ashina, M., Brandes, J. L., Kudrow, D., Lanteri-Minet, M., Osipova, V., Palmer, K., Picard, H., Mikol, D. D., & Lenz, R. A. (2018) · Cephalalgia · doi:10.1177/0333102418759786 · Cited by 566
Reuter, U., Goadsby, P. J., Lanteri-Minet, M., Wen, S., Hours-Zesiger, P., Ferrari, M. D., & Klatt, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32534-0 · Cited by 457
Adherence to oral migraine-preventive medications among patients with chronic migraine
Hepp, Z., Dodick, D. W., Varon, S. F., Gillard, P., Hansen, R. N., & Devine, E. B. (2015) · Cephalalgia · doi:10.1177/0333102414547138 · Cited by 433
Self-citationFerrari, M. D., Diener, H. C., Ning, X., Galic, M., Cohen, J. M., Yang, R., Mueller, M., Ahn, A. H., Schwartz, Y. C., Grozinski-Wolff, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31946-4 · Cited by 417
Metadata
- Authors
- Hepp, Z., Bloudek, L. M., & Varon, S. F.
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2014-01
- Volume
- 20
- Issue
- 1
- Pages
- 22-33
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- OpenAlex
- W73775937
- Cited by
- 333
- References
- 38
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.